Valuation: Uscom Limited

Market Cap 3.12M 2.16M 1.89M 1.74M 1.63M 3.06M 203M 20.94M 8.1M 100M 8.09M 7.92M 348M P/E 2024
-1.25x
P/E 2025 -0.88x
Enterprise Value 4.42M 3.05M 2.68M 2.47M 2.31M 4.33M 288M 29.64M 11.47M 142M 11.46M 11.21M 493M EV / Sales 2024
0.57x
EV / Sales 2025 2.06x
Free-Float
17.04%
Yield 2024 *
-
Yield 2025 -
1 year 0.01
Extreme 0.011
0.02
3 years 0.01
Extreme 0.011
0.05
5 years 0.01
Extreme 0.011
0.18
10 years 0.01
Extreme 0.011
0.53
Manager TitleAgeSince
Chief Executive Officer - 07/03/2011
Corporate Secretary 66 24/05/2016
Corporate Officer/Principal - 28/05/2018
Director TitleAgeSince
Chairman - 01/11/2009
Director/Board Member 66 23/08/2018
Director/Board Member 62 16/12/2019
Change 5-day change 1-year change 3-year change Capi.($)
+9.09%-.--%-36.84%-73.91% 2.16M
+1.44%+10.42%+24.49%-1.72% 191B
+1.25%-0.51%-24.24%+24.46% 143B
+1.75%+10.74%-2.62%-17.53% 139B
+0.07%-2.34%-57.71%-17.33% 65.74B
+1.18%+3.91%+17.67%+1.44% 52.27B
-0.52%-0.03%-26.94%-32.29% 43.55B
+0.37%+7.04%+13.89%+14.90% 38.41B
-0.66%+5.34%+5.49%+44.15% 36.76B
+1.26%+6.77%-12.16%-15.48% 29.91B
Average +1.52%+4.01%-9.90%-7.33% 73.95B
Weighted average by Cap. +1.04%+5.19%-3.84%+0.01%

Financials

2024 2025
Net sales 3.73M 2.57M 2.26M 2.08M 1.95M 3.65M 243M 25M 9.67M 120M 9.66M 9.45M 416M 2.58M 1.78M 1.56M 1.44M 1.35M 2.53M 168M 17.3M 6.69M 83.01M 6.69M 6.54M 288M
Net income -2.07M -1.43M -1.26M -1.16M -1.08M -2.03M -135M -13.92M -5.38M -66.79M -5.38M -5.26M -232M -3.3M -2.28M -2M -1.84M -1.73M -3.24M -215M -22.15M -8.57M -106M -8.56M -8.38M -369M
Net Debt -1.53M -1.06M -927K -854K -800K -1.5M -99.7M -10.27M -3.97M -49.27M -3.97M -3.88M -171M 1.3M 896K 785K 724K 678K 1.27M 84.48M 8.7M 3.37M 41.75M 3.36M 3.29M 145M
Logo Uscom Limited
Uscom Limited is an Australia-based medical technology company specializing in development and marketing of non-invasive cardiovascular and pulmonary medical devices. The Company offers three suites of devices in the field of cardiac, vascular and pulmonary monitoring: the USCOM 1A advanced haemodynamic monitor, the Uscom BP+ central blood pressure monitor, and the Uscom SpiroSonic digital ultrasonic spirometers. The USCOM 1A is a non-invasive advanced haemodynamic monitor that measures cardiovascular function, detects irregularities and is used to guide treatment. The Uscom BP+ is a supra-systolic oscillometric central blood pressure monitor which measures blood pressure and blood pressure waveforms at the heart, as well as in the arm, information only previously available using invasive cardiac catheterization. The Uscom SpiroSonic digital ultrasonic spirometers are high fidelity, digital, pulmonary function testing devices based on multi-path ultrasound technology.
Employees
35